TY  - GEN
AU  - Bacigalupo,A
AU  - Van Lint,M T
AU  - Valbonesi,M
AU  - Lercari,G
AU  - Carlier,P
AU  - Lamparelli,T
AU  - Gualandi,F
AU  - Occhini,D
AU  - Bregante,S
AU  - Valeriani,A
AU  - Piaggio,G
AU  - Pitto,A
AU  - Benvenuto,F
AU  - Figari,O
AU  - De Stefano,G
AU  - Caimo,A
AU  - Sessarego,M
TI  - Thiotepa cyclophosphamide followed by granulocyte colony-stimulating factor mobilized allogeneic peripheral blood cells in adults with advanced leukemia
SN  - 0006-4971
PY  - 1996///0909
KW  - Actuarial Analysis
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Bone Marrow
KW  - drug effects
KW  - Bone Marrow Diseases
KW  - chemically induced
KW  - Bone Marrow Transplantation
KW  - CD4 Lymphocyte Count
KW  - Cause of Death
KW  - Combined Modality Therapy
KW  - Cyclophosphamide
KW  - administration & dosage
KW  - Feasibility Studies
KW  - Female
KW  - Follow-Up Studies
KW  - Graft Survival
KW  - Graft vs Host Disease
KW  - etiology
KW  - Granulocyte Colony-Stimulating Factor
KW  - adverse effects
KW  - Hematopoietic Stem Cell Transplantation
KW  - Hematopoietic Stem Cells
KW  - Humans
KW  - Infections
KW  - Leukapheresis
KW  - Leukemia
KW  - blood
KW  - Lymphoma
KW  - Male
KW  - Middle Aged
KW  - Multiple Myeloma
KW  - Multiple Organ Failure
KW  - Myelodysplastic Syndromes
KW  - Pilot Projects
KW  - Primary Myelofibrosis
KW  - Salvage Therapy
KW  - Survival Analysis
KW  - Survival Rate
KW  - Thiotepa
KW  - Tissue Donors
KW  - Transplantation, Homologous
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Journal Article
ER  -